Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
BioXcel Therapeutics
BTAI
$24.5M
| $261K | ﹤0.01% |
12,726
+790
| +7% | +$26.4K |
|
|
MOND
3402
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $258K | ﹤0.01% |
107,568
-13,697
| -11% | -$30.5K |
|
3403
Priority Technology Holdings
PRTH
$544M
| $258K | ﹤0.01% |
48,838
| – | – |
|
3404
X4 Pharmaceuticals
XFOR
$377M
| $254K | ﹤0.01% |
14,607
+3,812
| +35% | +$125K |
|
3405
DLH Holdings
DLHC
$71M
| $251K | ﹤0.01% |
+23,788
| New | +$268K |
|
|
KLRS
3406
Kalaris Therapeutics
KLRS
$82.8M
| $249K | ﹤0.01% |
14,981
-5,055
| -25% | -$89.2K |
|
|
MAPS
3407
DELISTED
WM TECHNOLOGY INC A
MAPS
| $247K | ﹤0.01% |
237,515
+196,588
| +480% | +$216K |
|
3408
Amer Sports
AS
$21B
| $246K | ﹤0.01% |
+19,588
| New | +$287K |
|
3409
Sky Harbour Group
SKYH
$361M
| $246K | ﹤0.01% |
+26,604
| New | +$277K |
|
3410
CarParts.com
PRTS
$42.4M
| $246K | ﹤0.01% |
24,554
-45,596
| -65% | -$555K |
|
3411
Outlook Therapeutics
OTLK
$194M
| $245K | ﹤0.01% |
33,172
+15,442
| +87% | +$124K |
|
3412
Vanguard Total International Stock ETF
VXUS
$155B
| $245K | ﹤0.01% |
+4,055
| New | +$245K |
|
3413
Elbit Systems
ESLT
$36.8B
| $244K | ﹤0.01% |
1,383
-1,216
| -47% | -$237K |
|
|
EEX
3414
DELISTED
Emerald Holding
EEX
| $243K | ﹤0.01% |
42,666
+268
| +0.6% | +$1.61K |
|
3415
Caesarstone
CSTE
$71.6M
| $242K | ﹤0.01% |
+48,363
| New | +$274K |
|
3416
Cardiff Oncology
CRDF
$66.2M
| $242K | ﹤0.01% |
108,790
+92,391
| +563% | +$348K |
|
3417
Gaia
GAIA
$46.8M
| $242K | ﹤0.01% |
54,763
| – | – |
|
3418
Vanguard International Dividend Appreciation ETF
VIGI
$9.15B
| $241K | ﹤0.01% |
2,963
+91
| +3% | +$7.31K |
|
3419
Bausch + Lomb
BLCO
$6.06B
| $238K | ﹤0.01% |
+16,453
| New | +$247K |
|
3420
Intuitive Machines
LUNR
$1.97B
| $237K | ﹤0.01% |
+71,776
| New | +$357K |
|
3421
Waldencast
WALD
$219M
| $227K | ﹤0.01% |
63,202
| – | – |
|
3422
Global X MLP ETF
MLPA
$2.28B
| $226K | ﹤0.01% |
+4,670
| New | +$222K |
|
3423
Birkenstock
BIRK
$7.45B
| $226K | ﹤0.01% |
4,154
-244
| -6% | -$12.1K |
|
3424
LivePerson
LPSN
$22M
| $225K | ﹤0.01% |
25,821
-15,326
| -37% | -$147K |
|
3425
ICL Group
ICL
$6.69B
| $223K | ﹤0.01% |
52,147
-1,160
| -2% | -$5.46K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.